Literature DB >> 24257191

Metaplastic bone formation in the abdominal wall--an incidental finding in a patient with gastric cancer. Case report and hypothesis about its histogenesis.

Simona Gurzu1, Tivadar Bara, Tivadar Bara, Ioan Jung.   

Abstract

A 64-year-old man was hospitalized showing symptoms suggesting gastric cancer. The gastroscopy showed a 70 × 30-mm tumor. The intraoperatory findings indicated an inoperable gastric tumor located in the antrum and gastric body, which invaded the spleen and pancreas. The abdominal incision was closed without performing gastrectomy. Considering his general condition, after 1 month, he was transferred to our hospital. We decided to perform a total gastrectomy of necessity, spleno-pancreatectomy, and dissection of regional lymph nodes. The surgical incision was performed along to the previous one. At palpation, a well-defined nodule with hard consistency was observed in the surgical scar, which microscopically was composed by osteoblasts-lining mature lamellar bone intermingled with osteoid and cartilage in the intermediary layer and fibroblasts in the central area, without atypia. The final diagnosis was localized metaplastic bone formation. This is a rare condition which can be related to trauma or surgery and should be differentiated by foreign-body granuloma and osteosarcoma.

Entities:  

Mesh:

Year:  2013        PMID: 24257191     DOI: 10.1097/DAD.0b013e318285db5c

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Extensive Abdominal Wall Incisional Heterotopic Ossification Reconstructed with Component Separation and Strattice Inlay.

Authors:  Nergis Nina Suleiman; Lars Johan Marcus Sandberg
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-07-21

Review 2.  Successful treatment of a giant ossified benign mesenteric schwannoma.

Authors:  Ying-Sheng Wu; Shao-Yan Xu; Jing Jin; Ke Sun; Zhen-Hua Hu; Wei-Lin Wang
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.